AstraZeneca Seeks Ruling in Crestor Patent MDL
AstraZeneca Plc has asked a federal court for a ruling in its favor in a nearly 2-year-old patent infringement litigation the pharmaceutical giant has been pursuing against several generic-drug makers over...To view the full article, register now.
Already a subscriber? Click here to view full article